100mg Erlotinib Tablets IP

100mg Erlotinib Tablets IP Specification

Life Span
24 months from manufacturing date

Indication
For treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
30 tablets per box

Origin of Medicine
India

Brand Name
Erlotec 100 or as per brand availability

Packaging Type
Blister pack in carton box

Salt Composition
Erlotinib Hydrochloride

Drug Type
Anticancer medication, Prescription only anti-cancer medication

Ingredients
Erlotinib Hydrochloride 100mg

Physical Form
Film-coated tablet, Tablet

Function
Tyrosine kinase inhibitor, Anti-cancer therapy, EGFR tyrosine kinase inhibitor

Recommended For
Non-small cell lung cancer (NSCLC), pancreatic cancer

Dosage
As prescribed by physician; typically one 100mg tablet daily

Dosage Guidelines
Take on an empty stomach, at least one hour before or two hours after eating

Suitable For
Adults, Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Shape
Round, biconvex

Color
White to off-white

Prescription/Non Prescription
Prescription

Side Effects
Rash, diarrhea, loss of appetite, fatigue (Refer to full prescribing information)

Therapeutic Class
Antineoplastic agents

Minimum Order Quantity
One box (30 tablets)

Markings
May include strength or brand identification

ATC Code
L01EB02

Administration Route
Oral

100mg Erlotinib Tablets IP Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 100mg Erlotinib Tablets IP

New release: Erlotec 100 (or equivalent brand) 100mg Erlotinib Tablets IP offers an acclaimed, ineffable advancement in anti-cancer therapy. As an eminent tyrosine kinase inhibitor within the antineoplastic class (ATC Code: L01EB02), this splendiferous medicine is prescribed for adults battling non-small cell lung cancer (NSCLC) or pancreatic cancer. Each white to off-white, round, biconvex, film-coated tablet contains Erlotinib Hydrochloride 100mg. Price cuts now available for a minimum purchase of one box (30 tablets). Administer orally on an empty stomach, following physician's guidance. Store under 30C, shielded from moisture and light.

Key Use: Advanced Cancer Care for Adults

100mg Erlotinib Tablets IP are primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Designed exclusively for adult patients, its eminent role as an oral EGFR tyrosine kinase inhibitor makes it essential in targeted anti-cancer therapy. Usage demands strict prescription by a qualified physician, with the common regimen involving once-daily administration, ensuring optimal therapeutic outcomes.

Certifications, Payment, and Domestic Distribution

Our 100mg Erlotinib Tablets IP meet Indian and international pharmaceutical standards, ensuring ineffable confidence in quality. Expenditure is streamlined via multiple payment terms, facilitating hassle-free handover and order completion. Meticulously packaged in blister packs and delivered in carton boxes, the product is available across all major domestic markets within India, providing broad access and secure handling throughout distribution chains.

FAQ's of 100mg Erlotinib Tablets IP:

Q: How should 100mg Erlotinib Tablets IP be administered?

A: Erlotinib Tablets should be taken orally on an empty stomach, at least one hour before or two hours after eating, as prescribed by a physician.

Q: What are the primary indications for using Erlotinib 100mg Tablets?

A: These tablets are recommended for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer.

Q: When should I consult my doctor about potential side effects?

A: Consult your doctor immediately if you experience persistent rash, diarrhea, loss of appetite, or fatigue while using Erlotinib. Always refer to the full prescribing information for detailed guidance.

Q: Where are Erlotinib 100mg Tablets IP manufactured and supplied from?

A: The tablets are manufactured and supplied from India, adhering to stringent quality standards to ensure patient safety and efficacy.

Q: What is the process for placing a minimum order?

A: A minimum order consists of one box containing 30 tablets. Orders can typically be placed through certified suppliers or authorized traders in India.

Q: What are the key benefits of Erlotinib 100mg Tablets for eligible patients?

A: The eminent benefit of Erlotinib tablets is targeted anti-cancer activity, specifically inhibiting EGFR tyrosine kinase, thus slowing tumor growth and progression in NSCLC and pancreatic cancer.